Cargando…

Lymph node and pulmonary tuberculosis during upadacitinib treatment in a psoriatic arthritis patient

Detalles Bibliográficos
Autores principales:	Valor-Méndez, Larissa, Manger, Bernhard, Wacker, Jochen, Kleyer, Arnd, Schett, Georg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Letter to the Editor (Case report)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115673/ https://www.ncbi.nlm.nih.gov/pubmed/35601270 http://dx.doi.org/10.1093/rap/rkac032

Ejemplares similares

Re-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator
por: Valor-Méndez, Larissa, et al.
Publicado: (2022)

Hepatitis-E-Virus-Infektion bei einem Patienten mit rheumatoider Arthritis unter Baricitinib-Therapie
por: Valor-Méndez, Larissa, et al.
Publicado: (2021)

Massive nodulous lesions on hands and feet in a RA patient and improvement under baricitinib treatment
por: Valor-Méndez, Larissa, et al.
Publicado: (2020)

Sustained clinical remission under infliximab/rituximab combination therapy in a patient with granulomatosis with polyangiitis
por: Valor-Méndez, Larissa, et al.
Publicado: (2021)

Clinical Images: Tissue remodeling in autoimmune statin‐induced necrotizing autoimmune myopathy
por: Valor‐Méndez, Larissa, et al.
Publicado: (2022)

Upadacitinib for the treatment of psoriatic arthritis
por: Fonseca, Diogo, et al.
Publicado: (2023)

Similar Impact of Psoriatic Arthritis and Rheumatoid Arthritis on Objective and Subjective Parameters of Hand Function
por: Liphardt, Anna‐Maria, et al.
Publicado: (2020)

Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination
por: Fagni, Filippo, et al.
Publicado: (2022)

Performance of a Handheld Ultrasound Device to Assess Articular and Periarticular Pathologies in Patients with Inflammatory Arthritis
por: Corte, Giulia, et al.
Publicado: (2021)

Autoinflammation leading to autoimmunity in adult-onset Still’s disease: more than simple coincidence?
por: Valor-Méndez, Larissa, et al.
Publicado: (2021)

Quantification of hand muscle volume and composition in patients with rheumatoid arthritis, psoriatic arthritis and psoriasis
por: Friedberger, Andreas, et al.
Publicado: (2020)

Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2
por: Mease, Philip J, et al.
Publicado: (2021)

Misdiagnosis of polymyositis in a young female patient with occult limb-girdle muscular dystrophy
por: Valor-Méndez, Lara, et al.
Publicado: (2023)

Tolerability of low to moderate biomechanical stress during leisure sport activity in patients with psoriasis and psoriatic arthritis
por: Fagni, Filippo, et al.
Publicado: (2023)

Biomechanical stress in the context of competitive sports training triggers enthesitis
por: Simon, David, et al.
Publicado: (2021)

Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients
por: Simon, David, et al.
Publicado: (2019)

Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritis
por: Nash, Peter, et al.
Publicado: (2021)

MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
por: Charles-Schoeman, Christina, et al.
Publicado: (2023)

Simultaneous quantification of bone erosions and enthesiophytes in the joints of patients with psoriasis or psoriatic arthritis - effects of age and disease duration
por: Simon, David, et al.
Publicado: (2018)

Digital Approaches for a Reliable Early Diagnosis of Psoriatic Arthritis
por: Fagni, Filippo, et al.
Publicado: (2021)

Upadacitinib for rheumatoid arthritis
Publicado: (2020)

Enthesitis in psoriatic arthritis (Part 1): pathophysiology
por: Araujo, Elizabeth G, et al.
Publicado: (2020)

Comparison of the axillary lymph node between rheumatoid arthritis and psoriatic arthritis with computed tomography
por: Fukuda, Takeshi, et al.
Publicado: (2022)

COVID-19 revisiting inflammatory pathways of arthritis
por: Schett, Georg, et al.
Publicado: (2020)

Advanced machine learning for predicting individual risk of flares in rheumatoid arthritis patients tapering biologic drugs
por: Vodencarevic, Asmir, et al.
Publicado: (2021)

Secukinumab leads to shifts from stage-based towards response-based disease clusters—comparative data from very early and established psoriatic arthritis
por: Kampylafka, Eleni, et al.
Publicado: (2020)

Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study
por: Kampylafka, Eleni, et al.
Publicado: (2018)

Cinematic rendering in rheumatic diseases—Photorealistic depiction of pathologies improves disease understanding for patients
por: Pachowsky, Milena L., et al.
Publicado: (2022)

Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis
por: Burmester, Gerd R, et al.
Publicado: (2023)

Upadacitinib pharmacokinetics and exposure‐response analyses of efficacy and safety in psoriatic arthritis patients – Analyses of phase III clinical trials
por: Muensterman, Elena, et al.
Publicado: (2021)

Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials
por: Burmester, Gerd R., et al.
Publicado: (2021)

Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies
por: Baraliakos, Xenofon, et al.
Publicado: (2023)

Development of three-dimensional prints of arthritic joints for supporting patients’ awareness to structural damage
por: Kleyer, Arnd, et al.
Publicado: (2017)

Tuberculosis of Lymph Node Combined with Pulmonary Mucormycosis
por: Yu, Shan, et al.
Publicado: (2015)

Th2 and eosinophil responses suppress inflammatory arthritis
por: Chen, Zhu, et al.
Publicado: (2016)

Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials
por: McInnes, Iain B, et al.
Publicado: (2022)

Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study
por: McInnes, Iain B., et al.
Publicado: (2022)

Antibodies against citrullinated proteins of IgA isotype are associated with progression to rheumatoid arthritis in individuals at-risk
por: Sokolova, Maria V, et al.
Publicado: (2023)

The Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis in Japan
por: Yamaoka, Kunihiro, et al.
Publicado: (2021)

Lymphomatoid papulosis during upadacitinib treatment for rheumatoid arthritis
por: Iinuma, Shin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t1va286nt3n2gf8u7mvps53rer